Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-04-04 00:00:00 ET · period of report 2023-03-31 · accession 0001209191-23-022689 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-04 | 2023-03-31 | VRTX | Ambrose Kristen | SVP, CAO | F - Tax | $313.74 | -176 | 7,127 | -2% | -$55.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-31 | F | D | 176 | $313.74 | 7,127 | D | — | — |